These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38445489)

  • 21. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
    Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction.
    Liechti MD; van der Lely S; Knüpfer SC; Abt D; Kiss B; Leitner L; Mordasini L; Tornic J; Wöllner J; Mehnert U; Bachmann LM; Burkhard FC; Engeler DS; Pannek J; Kessler TM
    NEJM Evid; 2022 Nov; 1(11):EVIDoa2200071. PubMed ID: 38319849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial experience with sacral neuromodulation for the treatment of lower urinary tract dysfunction in Brazil.
    Rios LA; Averbeck MA; Franca W; Sacomani CA; Almeida FG; Gomes CM
    Int Braz J Urol; 2016; 42(2):312-20. PubMed ID: 27176186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of Sacral Neuromodulation in Patients With Underlying Neurologic Lower Urinary Tract Dysfunction and Fecal Incontinence.
    Schwarztuch Gildor O; Neheman A; Vainrib M
    Urology; 2024 Jun; 188():54-62. PubMed ID: 38417466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Functional Outcomes of S3 Sacral Neuromodulation for the Treatment of Idiopathic Overactive Bladder.
    Ismail S; Chartier-Kastler E; Perrouin-Verbe MA; Rose-Dite-Modestine J; Denys P; Phé V
    Neuromodulation; 2017 Dec; 20(8):825-829. PubMed ID: 28967986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sacral Neuromodulation for Genitourinary Problems.
    Banakhar M; Hassouna M
    Prog Neurol Surg; 2015; 29():192-9. PubMed ID: 26394134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of neuromodulation in patients with neurogenic overactive bladder.
    Lay AH; Das AK
    Curr Urol Rep; 2012 Oct; 13(5):343-7. PubMed ID: 22865208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation.
    Starkman JS; Duffy JW; Wolter CE; Kaufman MR; Scarpero HM; Dmochowski RR
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Feb; 19(2):277-82. PubMed ID: 17671752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
    Tilborghs S; De Wachter S
    Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Influence of Electrode Configuration Changes on the Sensory and Motor Response During (Re)Programming in Sacral Neuromodulation.
    Tilborghs S; Van de Borne S; Vaganée D; De Win G; De Wachter S
    Neuromodulation; 2022 Dec; 25(8):1173-1179. PubMed ID: 35088741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction.
    Wöllner J; Krebs J; Pannek J
    Spinal Cord; 2016 Feb; 54(2):137-40. PubMed ID: 26215913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The science behind programming algorithms for sacral neuromodulation.
    Knowles CH; de Wachter S; Engelberg S; Lehur P; Matzel KE; Zirpel L;
    Colorectal Dis; 2021 Mar; 23(3):592-602. PubMed ID: 33010084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction?
    Averbeck MA; Moreno-Palacios J; Aparicio A
    Int Braz J Urol; 2020; 46(6):891-901. PubMed ID: 32758301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Autonomic Nervous System Response to Direct Sacral Nerve Root Stimulation in Lower Urinary Tract Dysfunction: A New Approach to Understand the Mechanism of Action of Sacral Nerve Modulation.
    Biardeau X; Wojtanowski A; Tilborghs S; De Jonckheere J; Vermersch P; De Wachter S
    J Urol; 2024 Aug; 212(2):342-350. PubMed ID: 38780045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of sacral nerve modulation for treatment of overactive bladder].
    Braun PM; Böhler G
    Urologe A; 2006 Jul; 45(7):835-40. PubMed ID: 16773383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of sacral neuromodulation: a treatment for patients with symptoms of lower urinary tract dysfunction.
    Fletcher N
    Br J Nurs; 2020 Aug; 29(15):848-856. PubMed ID: 32790556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
    Marinkovic SP; Ford JC
    BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder.
    Zillioux J; Lewis KC; Hettel D; Goldman HB; Vasavada SP; Gill BC
    Neurourol Urodyn; 2023 Mar; 42(3):623-630. PubMed ID: 36701189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.